These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9315633)

  • 21. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.
    Burýsek L; Yeow WS; Lubyová B; Kellum M; Schafer SL; Huang YQ; Pitha PM
    J Virol; 1999 Sep; 73(9):7334-42. PubMed ID: 10438822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation.
    Lu R; Au WC; Yeow WS; Hageman N; Pitha PM
    J Biol Chem; 2000 Oct; 275(41):31805-12. PubMed ID: 10924517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors.
    Lubyova B; Pitha PM
    J Virol; 2000 Sep; 74(17):8194-201. PubMed ID: 10933732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2001 Jan; 75(1):341-50. PubMed ID: 11119603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 replication and transcription activator regulates viral and cellular genes via interferon-stimulated response elements.
    Zhang J; Wang J; Wood C; Xu D; Zhang L
    J Virol; 2005 May; 79(9):5640-52. PubMed ID: 15827179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and function of IRF-7.
    Zhang L; Pagano JS
    J Interferon Cytokine Res; 2002 Jan; 22(1):95-101. PubMed ID: 11846980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production.
    Xu D; Brumm K; Zhang L
    J Biol Chem; 2006 Apr; 281(14):9163-9. PubMed ID: 16469740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
    Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
    Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of type I interferon gene expression by interferon regulatory factor-3.
    Schafer SL; Lin R; Moore PA; Hiscott J; Pitha PM
    J Biol Chem; 1998 Jan; 273(5):2714-20. PubMed ID: 9446577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Jan; 71(1):354-61. PubMed ID: 8985357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
    Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
    J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    Ling PD; Ryon JJ; Hayward SD
    J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha.
    Flowers CC; Flowers SP; Nabel GJ
    Mol Med; 1998 Jun; 4(6):402-12. PubMed ID: 10780883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.